What you'll find here at MDLinx Rheumatology: The top rheumatology clinical articles of the day, plus MDLinx exclusive content
Your Unread Messages in Rheumatology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Hypovitaminosis D common in SLE
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Clinical Pearls for Rheumatologists
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
1 Marfan syndrome with antineutrophil cytoplasmic antibody-associated systemic vasculitis presenting as severe anaemia and haematuria after the Bentall procedure European Journal of Cardio-Thoracic Surgery, May 16, 2013
2 Four cases of MPO-ANCA-positive vasculitis with otitis media, and review of the literature Modern Rheumatology, May 16, 2013 Review Article
3 Dnase1l3 mutations in hypocomplementemic urticarial vasculitis syndrome Arthritis & Rheumatism, May 16, 2013 Review Article
4 Changes in biomarkers after therapeutic intervention in temporal arteries cultured in Matrigel: a new model for preclinical studies in giant-cell arteritis Annals of Rheumatic Diseases, May 16, 2013 Clinical Article
5 Giant cell arteritis associated with chronic active Epstein-Barr virus infection Full Text Rheumatismo, May 16, 2013
6 Statin Use in Giant Cell Arteritis: A Retrospective Study The Journal of Rheumatology, May 2, 2013 Clinical Article
7 Peg-IFN α/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24 Annals of Rheumatic Diseases, May 2, 2013 Clinical Article
8 Prognosis of vasculitis associated myelodysplasia Autoimmunity Reviews, May 2, 2013 Review Article
9 ANA (+) ANCA (+) systemic vasculitis associated with the use of minocycline: case-based review Clinical Rheumatology, May 2, 2013 Review Article
10 p38 mitogen-activated protein kinase (p38 MAPK)-mediated autoimmunity: Lessons to learn from ANCA vasculitis and pemphigus vulgaris Autoimmunity Reviews, May 2, 2013 Review Article
11 Immune complexes activate human endothelium involving the cell-signaling HMGB1-RAGE axis in the pathogenesis of lupus vasculitis Laboratory Investigation, May 2, 2013
12 Cryofibrinogenemia JCR: Journal of Clinical Rheumatology, April 18, 2013 Review Article
13 Vasculitis in the intensive care unit Best Practice & Research Clinical Rheumatology, April 18, 2013 Review Article
14 Imaging in vasculitis Best Practice & Research Clinical Rheumatology, April 18, 2013 Clinical Article
15 Infections in vasculitis Best Practice & Research Clinical Rheumatology, April 18, 2013 Clinical Article
16 Thrombosis in vasculitis Best Practice & Research Clinical Rheumatology, April 18, 2013 Review Article
17 Fertility and pregnancy in vasculitis Best Practice & Research Clinical Rheumatology, April 18, 2013 Review Article
18 Diagnosis and treatment of cutaneous leukocytoclastic vasculitis International Journal of Clinical Rheumatology, April 18, 2013 Clinical Article
19 Urinary Biomarkers in Relapsing Antineutrophil Cytoplasmic Antibody-associated Vasculitis The Journal of Rheumatology, April 18, 2013 Clinical Article
20 Hypocomplementemic urticarial vasculitis syndrome in three siblings Rheumatology International, April 18, 2013
21 ANCA-associated vasculitis patients have defective Treg function exacerbated by presence of a suppression-resistant effector population Arthritis & Rheumatism, April 18, 2013 Review Article
22 Autoantibodies against complement C1q in patients with Behcet’s disease: association with vascular involvement Modern Rheumatology, April 18, 2013 Review Article
23
Is there a place for cyclophosphamide in the treatment of giant-cell arteritis? A case series and systematic review
Seminars in Arthritis and Rheumatism, March 23, 2013
Evidence Based Medicine
Clinical Article
Exclusive Author Commentary
24 Tocilizumab improves systemic rheumatoid vasculitis with necrotizing crescentic glomerulonephritis Modern Rheumatology, March 23, 2013 Clinical Article
25 Prognostic factors of survival in patients with non-infectious mixed cryoglobulinaemia vasculitis: data from 242 cases included in the CryoVas survey Annals of Rheumatic Diseases, March 23, 2013 Clinical Article
26 Cardiovascular disease due to accelerated atherosclerosis in systemic vasculitides Best Practice & Research Clinical Rheumatology, March 23, 2013 Clinical Article
27 B lymphocytes may play a significant role in large-vessel vasculitis International Journal of Clinical Rheumatology, March 23, 2013 Review Article
28 ANCA-associated vasculitis and malignancy: Current evidence for cause and consequence relationships Best Practice & Research Clinical Rheumatology, March 23, 2013 Clinical Article
29 Update on the classification of vasculitis Best Practice & Research Clinical Rheumatology, March 23, 2013 Review Article
30 NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica Annals of Rheumatic Diseases, March 23, 2013 Review Article
31 18FDG-PET in assessing disease activity in Takayasu arteritis: a meta-analysis Clinical and Experimental Rheumatology Online, March 23, 2013 Evidence Based Medicine Clinical Article
32 Serum IL-33 levels and skin mRNA expression in Behcet's disease Clinical and Experimental Rheumatology Online, March 9, 2013 Review Article
In a study involving 74 patients with juvenile idiopathic arthritis (JIA), 26 patients had detectable anti-citrullinated protein antibodies (ACPA). The ACPA titers correlated with disease progression at baseline and after a median follow-up of 11.5 months. In addition to predicting disease severity and progression, the authors concluded that ACPA were superior to IgM-RF in diagnosing JIA.
Read the article summaryIn a study involving 208 patients with SLE followed for 12 years, 42 deaths occurred, 48% of which were considered to be cardiovascular mortalities. Age, increased cystatin C levels, and arterial disease were predictive of all-cause mortality. Cigarette smoking and increased sVCAM-1, hsCRP, abeta2GP1, and aPL antibody levels were predictive of cardiovascular mortality.
Read the article summaryIn a study conducted at the University of Geneva involving 118 patients with rheumatoid arthritis, but without cardiovascular disease at baseline, the 10-year Framingham cardiovascular risk score (FRS) was improved with the inclusion of the anti-apoA-1 antibody titer. The median follow-up was 9 years and the incidence of cardiovascular disease was 16%. Other biomarkers, including the NT-proBNP, oxLDL, CRP, and RF levels and the anti-citrullinated peptide antibody titer, did not improve the FRS.
Read the article summary1 Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) Current Medical Research and Opinion, April 3, 2013
2 Antibiotics for Treatment of Reactive Arthritis: A Systematic Review and Metaanalysis The Journal of Rheumatology, April 18, 2013 Evidence Based Medicine Review Article
3 EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis Annals of Rheumatic Diseases, April 10, 2013
4 Targeted therapies for systemic sclerosis Nature Reviews Rheumatology , April 10, 2013
5 Complementary and alternative exercise for fibromyalgia: a meta-analysis Journal of Pain Research, April 2, 2013 Free full text
6 Late-onset systemic lupus erythematosus: clinical features, course, and prognosis Clinical Rheumatology, March 26, 2013
7 Statin Use in Giant Cell Arteritis: A Retrospective Study The Journal of Rheumatology, April 3, 2013
8 Osteoarthritis guidelines: a progressive role for topical nonsteroidal anti-inflammatory drugs Journal of Multidisciplinary Healthcare, April 4, 2013 Review Article Clinical Guideline
9 Safety of Abatacept Administered Intravenously in Treatment of Rheumatoid Arthritis: Integrated Analyses of up to 8 Years of Treatment from the Abatacept Clinical Trial Program The Journal of Rheumatology, April 16, 2013
10 New therapeutics in systemic lupus erythematosus Current Opinion in Rheumatology, April 1, 2013
11 New treatments for osteoarthritis Current Opinion in Rheumatology, March 29, 2013
12 The association of gout with sleep disorders: a cross-sectional study in primary care BMC Musculoskeletal Disorders, April 5, 2013 Free full text
13 Intra-articular corticosteroid injection in osteoarthritis of the knee and hip: Factors predicting pain relief--A systematic review Seminars in Arthritis and Rheumatism, February 4, 2013 Evidence Based Medicine
14 Novel aspects of Sjogren's syndrome in 2012 BMC Medicine, April 16, 2013 Free full text
15 Creatine supplementation in fibromyalgia: A double-blind, randomized, placebo-controlled trial Arthritis Care & Research , April 3, 2013
16 Current diagnostic tools for Sjogrens syndrome International Journal of Clinical Rheumatology, April 3, 2013
17 A meta-analysis of healing and prevention of digital ulcers (DU) in systemic sclerosis (SSc) Arthritis Care & Research , April 2, 2013 Evidence Based Medicine
18 The Early Protective Effect of Hydroxychloroquine on the Risk of Cumulative Damage in Patients with Systemic Lupus Erythematosus The Journal of Rheumatology, April 18, 2013
19 The impact of statin use on lipid levels in statin-naive patients with rheumatoid arthritis (RA) vs. non-RA subjects: Results from a population-based study Arthritis Care & Research , April 17, 2013
20 Safety of Rituximab in Combination with Other Biologic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: An Open-label Study The Journal of Rheumatology, April 2, 2013
Indexed Journals in Rheumatology: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatology more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close